C21orf88 anticorps (AA 1-100) (Cy7)

N° du produit ABIN1707291

Détail du produit anti-C21orf88 anticorps (Cy7)

Antigène: C21orf88 (C21ORF88) (Chromosome 21 Open Reading Frame 88 (C21ORF88))

Épitope: AA 1-100

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp C21orf88 est conjugé à/à la Cy7

Application: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Homologie: Human

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human C21orf88

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur C21orf88

Antigène: C21orf88 (C21ORF88) (Chromosome 21 Open Reading Frame 88 (C21ORF88))

Autre désignation: C21orf88 (C21ORF88 Produits)

Synonymes: anticorps B3GALT5 antisense RNA 1, anticorps B3GALT5-AS1

Sujet:

Synonyms: chromosome 21 open reading frame 88, Putative uncharacterized protein C21orf88, CU088_HUMAN.

Background: The smallest of the human chromosomes, 21 makes up about 1.5 % of the human genome. Chromosome 21 contains nearly 300 genes and 47 million base pairs. Down syndrome, also known as trisomy 21, is the disease most commonly associated with chromosome 21. Alzheimer's disease, Jervell and Lange-Nielsen syndrome and amyotrophic lateral sclerosis are also associated with chromosome 21. Translocations are found to occur between chromosome 21 and 8, and chromosome 21 and 12, in certain leukemias. The C21orf88 gene product has been provisionally designated C21orf88 pending further characterization.